Cerebral sinovenous thrombosis during asparaginase treatment: Case 3

Hamostaseologie

Volumn 23, Issue 3, 2003, Pages 109-112

  Leibundgut, K ^c   Hirt, A ^d   Zwicky, C ^a   Wuillemin, W A ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c Universitats Kinderklinik   (Switzerland)

^d NONE

Author keywords

Acute lymphoblastic leukaemia; Asparaginase; Child; Thrombosis

Indexed keywords

ASPARAGINASE; FRESH FROZEN PLASMA; HEPARIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CEREBRAL SINOVENOSUS THROMBOSIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOGENESIS; PROPHYLAXIS; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0042433381     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619586     Document Type: Article

References (9)

1. DeVeber G, Andrew M, Adams C et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
2. Hill JM, Roberts J, Loeb E et al. L-asparaginase therapy for leukemia and other malignant neoplasms. JAMA 1967; 202: 882-8.
3. Junker R, Koch HG, Auberger K et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568-72.
4. Mitchell LG, Sutor AH, Andrew M. Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. Semin Thromb Hemost 1995; 21: 390-401.
5. Nowak-Göttl U, Junker R, Hartmeier M et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999; 100: 743-8.
6. Nowak-Göttl U, Strater R, Heinecke A et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylene-tetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678-82.
7. Nowak-Göttl U, Wermes C, Junker R et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999; 93: 1595-9.
8. von Scheven E, Athreya BH, Rose CD et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 339-45.
9. Wilimas JA, Hudson M, Rao B et al. Late vascular occlusion of central lines in pediatric malignancies. Pediatrics 1998; 101: E7.